Recruiting

Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)

ClinicalTrials.gov IDNCT07569458

PhaseNA

Enrollment30

SponsorUniversity of Southern Denmark

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Ischemic Heart Disease (IHD), Anxiety, Depression

About this study

The goal of this feasibility study is to assess if the personalised online psychological intervention MY-CHOICE is acceptable to adults with ischemic heart disease and anxiety or depression. It will also examine the reasons for drop-out. The main questions the study aims to answer are: How many participants complete the intervention and what are the reasons for drop-out. And what are the pre-post change scores on anxiety and depression. Participants will: Complete the MY-CHOICE intervention consisting of 6-12 weeks with online modules on various topics based on individual needs in combination with video- or telephone calls with a therapist (psychologist or a trained master student in Psychology) on a need-to basis. Answer a set of questionnaires pre and post intervention. Participate in a brief interview post intervention.

Interventions

Other: Online psychological therapy — Online psychological treatment of anxiety and depression for patients with ischemic heart disease tailored to individual needs. The treatment includes access to an online treatment platform offering psychological content and written communication with the therapist and telephone-video conversations with the therapist. The intervention is tailored to meet the patients´ individual needs.

Primary outcomes

Drop-out rate (From enrollment to end of treatment i.e., from 0 to 13 weeks)

Eligibility information

Inclusion Criteria: * ischemic heart disease (diagnostic codes I20-I25), * referred for CR with a positive screen for depression and/or anxiety with the Hospital Anxiety and Depression Scale (HADS ≥ 8) * access to and ability to use a computer or tablet * proficient in the Danish language Exclusion Criteria: * Severe psychiatric disorder (i.e., borderline disorder, schizophrenia or bipolar disorder) that requires psychiatric care * severe cognitive difficulties (e.g., severe brain damage, mental retardation, or dementia) that will prevent patients from participating * endorsement of suicidal ideation with suicidal thoughts (purpose designed questions) that cannot be handled in the intervention * participation in other intervention studies focused (unless they are clinical studies) * seeing a psychologist or mental health professional for the treatment of anxiety and depression * not being able or willing to spend 3-4 hours on the intervention each week * experiencing significant life stressors that hinder adherence to the MY-CHOICE treatment

Study locations

Aalborg University Hospital, Department of Cardiology, Aalborg, 9000 Denmark
Aarhus University Hospital, Department of Cardiology, Aarhus, 8200 Denmark
Zealand University Hospital, Roskilde, Department of Cardiology, Roskilde, 4000 Denmark

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.